Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
Eur Urol Focus. 2019 Jan;5(1):69-76. doi: 10.1016/j.euf.2017.05.011. Epub 2017 Jun 17.
Eur Urol Focus. 2019.
PMID: 28753811
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
Yang DD, Muralidhar V, Mahal BA, Labe SA, Nezolosky MD, Vastola ME, King MT, Martin NE, Orio PF 3rd, Choueiri TK, Trinh QD, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.
Yang DD, et al. Among authors: labe sa.
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):338-343. doi: 10.1016/j.ijrobp.2017.02.020. Epub 2017 Feb 21.
Int J Radiat Oncol Biol Phys. 2017.
PMID: 28463152
Item in Clipboard
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.
Yang DD, et al. Among authors: labe sa.
Urol Oncol. 2017 Sep;35(9):542.e25-542.e32. doi: 10.1016/j.urolonc.2017.04.018. Epub 2017 May 19.
Urol Oncol. 2017.
PMID: 28533151
Item in Clipboard
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.
Yang DD, Mahal BA, Muralidhar V, Boldbaatar N, Labe SA, Nezolosky MD, Vastola ME, Beard CJ, Martin NE, Mouw KW, Orio PF 3rd, King MT, Nguyen PL.
Yang DD, et al. Among authors: labe sa.
Cancer. 2017 Dec 15;123(24):4832-4840. doi: 10.1002/cncr.30948. Epub 2017 Aug 22.
Cancer. 2017.
PMID: 28832984
Free article.
Item in Clipboard
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Orio PF 3rd, King MT, Martin NE, Mouw KW, Trinh QD, Nguyen PL.
Yang DD, et al. Among authors: labe sa.
Clin Genitourin Cancer. 2018 Jun;16(3):226-234. doi: 10.1016/j.clgc.2017.10.013. Epub 2017 Nov 9.
Clin Genitourin Cancer. 2018.
PMID: 29196209
Item in Clipboard
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer.
Yang DD, Muralidhar V, Mahal BA, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Martin NE, King MT, Mouw KW, Choueiri TK, Trinh QD, Nguyen PL, Orio PF 3rd.
Yang DD, et al. Among authors: labe sa.
Urol Oncol. 2020 Sep;38(9):735.e9-735.e15. doi: 10.1016/j.urolonc.2020.05.023. Epub 2020 Jul 10.
Urol Oncol. 2020.
PMID: 32654951
Item in Clipboard
Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes.
Labe SA, Wang X, Lehrer EJ, Kishan AU, Spratt DE, Lin C, Morgans AK, Ponsky L, Garcia JA, Garrett S, Wang M, Zaorsky NG.
Labe SA, et al.
Clin Genitourin Cancer. 2022 Aug;20(4):371-380. doi: 10.1016/j.clgc.2022.02.008. Epub 2022 Feb 24.
Clin Genitourin Cancer. 2022.
PMID: 35383004
Free PMC article.
Item in Clipboard
NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair.
Deraska PV, O'Leary C, Reavis HD, Labe S, Dinh TK, Lazaro JB, Sweeney C, D'Andrea AD, Kozono D.
Deraska PV, et al.
Cell Death Discov. 2018 Feb 7;4:10. doi: 10.1038/s41420-017-0008-3. eCollection 2018 Dec.
Cell Death Discov. 2018.
PMID: 29531807
Free PMC article.
Item in Clipboard
Cite
Cite